Bialmed Sp. z o.o. secures contract for General anti-infectives for systemic use, vaccines, antineoplastic and immunomodulating agents - purchase and successive delivery of medicinal products for drug, chemotherapy and RDTL programs

Poland, Dec. 2 -- Poland based Bialmed Sp. z o.o. has secured contract from Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji for General anti-infectives for systemic use, vaccines, antineoplastic and immunomodulating agents - purchase and successive delivery of medicinal products for drug, chemotherapy and RDTL programs. The value of the contract is worth 40337250 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....